Cancer statistics, 2012

@article{Siegel2012CancerS2,
  title={Cancer statistics, 2012},
  author={Rebecca L. Siegel and Deepa Naishadham and Ahmedin Jemal},
  journal={CA: A Cancer Journal for Clinicians},
  year={2012},
  volume={62}
}
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. A total of 1,638,910 new cancer cases… Expand
View on Wiley
onlinelibrary.wiley.com
10,312 Citations
Highly Influential Citations
105
Background Citations
836
Methods Citations
16
Results Citations
11

Paper Mentions

Interventional Clinical Trial
Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination
This trial is a randomized, open-label Phase I-2 multi-center study designed to evaluate the effect of Carboplatin-Paclitaxel-Bevacizumab (in combination and maintenance) vs… Expand
ConditionsAdvanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer
InterventionDrug
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
March 2021 - March 2025
Interventional Clinical Trial
Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)
Cabozantinib in patients with advanced penile squamous cell carcinoma (PSCC): an open-label, single-center, phase 2, single-arm trial (CaboPen)  
ConditionsPenile Squamous Cell Carcinoma
InterventionDrug
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
August 2019 - September 2022
Interventional Clinical Trial
Radiotherapy for Oligometastatic Prostate Cancer
The purpose of this phase II study is to evaluate the outcomes of patients treated with an investigational radiation regimen using stereotactic radiotherapy for oligometastatic… Expand
ConditionsOligometastatic Prostate Cancer
InterventionRadiation
University of Florida
May 2013 - January 2022
Observational Patient Registry Clinical Trial
trūFreeze® Spray Cryotherapy Patient Registry
To collect efficacy and outcomes data related to the use of trūFreeze® spray cryotherapy for the treatment of unwanted tissue in the pulmonary and gastrointestinal settings.  
ConditionsBarrett Esophagus, Bronchial Neoplasm, Esophageal Dysplasia, (+3 more)
InterventionDevice
US Endoscopy Group Inc.
April 2013 - January 2022

10,312 Citations

Citation Type

Citation Type

Cancer statistics, 2017
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer… Expand
Cancer statistics, 2018
TLDR
The combined cancer death rate dropped continuously from 1991 to 2015 by a total of 26%, translating to approximately 2,378,600 fewer cancer deaths than would have been expected if death rates had remained at their peak. Expand
Trends in prostate cancer in the United States.
  • O. Brawley
  • Medicine
  • Journal of the National Cancer Institute. Monographs
  • 2012
TLDR
Outcomes studies among men treated with radical prostatectomy show that greater than 30% serum prostate-specific antigen relapse rates are common, which suggests that many men who are diagnosed with "localized early stage disease" actually have "apparently localizedEarly stage disease," which is really low-volume metastatic disease. Expand
Cancer statistics for Hispanics/Latinos, 2012
TLDR
Hispanics/Latinos are the largest and fastest growing major demographic group in the United States, accounting for 16.3% (50.5 million/310 million) of the US population in 2010 and have lower incidence and death rates than non‐Hispanic whites for all cancers combined and for the 4 most common cancers. Expand
An updated report of the trends in cancer incidence and mortality in Japan.
TLDR
The analysis of cancer trends in Japan revealed a recent decrease in mortality and a continuous increase in incidence, which are considered to reflect changes in the underlying risk factors such as tobacco smoking and infection, and are partially explained by early detection and improved treatment. Expand
Epidemiology, Incidence and Mortality of Breast Cancer in Asia.
TLDR
This study aimed to investigate the incidence and mortality of breast cancer in the world using age-specific incidenceand mortality rates for the year 2012 acquired from the global cancer project (GLOBOCAN 2012) as well as data about incidence andortality of the cancer based on national reports. Expand
Prostate Cancer Epidemiology
TLDR
The incidence of prostate cancer spiked in the United States in the early 1990s and was followed by a sharp decline from 1992 to 1995 during which incidence rates returned to a new baseline, likely due to the fact that increased screening in prior years had successfully diagnosed much of the previously undetected prostate cancer patients in the population. Expand
Declining second primary ovarian cancer after first primary breast cancer.
TLDR
Persistently elevated SIRs along with decreasing absolute rates over the entire study period suggest that ovarian cancers in both the general population and survivors of breast cancer are declining in parallel, possibly because of common risk factor exposures. Expand
Sex disparities in cancer mortality: the risks of being a man in the United States.
TLDR
Men are more likely to have nonsex specific cancer than women and more likelyto die of the cancer even after controlling for the incidence, and this discrepancy has been stable for the last decade. Expand
Contemporary incidence and mortality rates of kidney cancer in the United States.
  • G. Gandaglia, P. Ravi, +8 authors Maxine Sun
  • Medicine
  • Canadian Urological Association journal = Journal de l'Association des urologues du Canada
  • 2014
TLDR
There is a persisting upward trend in incidence and mortality of localized RCC in contemporary years, and incidence rates of distant stage remained unchanged in long- and short-term trends. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 50 REFERENCES
Trends in Breast Cancer by Race and Ethnicity
TLDR
Trends in incidence, mortality, and survival rates of female breast cancer in the United States by race and ethnicity are described and continued efforts are needed to increase the availability of high‐quality mammography and treatment to all segments of the population. Expand
Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control
TLDR
Although the decrease in overall cancer incidence and death rates is encouraging, large state and regional differences in lung cancer trends among women underscore the need to maintain and strengthen many state tobacco control programs. Expand
A New Method of Estimating United States and State‐level Cancer Incidence Counts for the Current Calendar Year
TLDR
A new method is presented that uses statistical models of cancer incidence that incorporate potential predictors of spatial and temporal variation of cancer occurrence and that account for delay in case reporting and then projects these estimated numbers of cases ahead 4 years using a piecewise linear (joinpoint) regression method. Expand
Impact of reporting delay and reporting error on cancer incidence rates and trends.
TLDR
Investigating the impact of reporting delay and reporting error on incidence rates and trends for cancers of the female breast, colorectal, lung/bronchus, prostate, and melanoma found reporting-adjusted cancer incidence rates are valuable in precisely determining current cancer incidence levels and trends and in monitoring the timeliness of data collection. Expand
Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR)… Expand
Cancer Disparities by Race/Ethnicity and Socioeconomic Status
TLDR
Differences in cancer incidence, mortality, and survival in relation to race/ethnicity, and census data on poverty in the county or census tract of residence are highlighted. Expand
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
TLDR
This year's report includes trends in colorectal cancer incidence and death rates and highlights the use of microsimulation modeling as a tool for interpreting past trends and projecting future trends to assist in cancer control planning and policy decisions. Expand
Effect of screening and adjuvant therapy on mortality from breast cancer.
TLDR
Seven statistical models showed that both screening mammography and treatment have helped reduce the rate of death from breast cancer in the United States. Expand
Quantifying the role of PSA screening in the US prostate cancer mortality decline
TLDR
PSA screening may account for much, but not all, of the observed drop in prostate cancer mortality, and other factors, such as changing treatment practices, may also have played a role in improving prostate cancer outcomes. Expand
The global health burden of infection‐associated cancers in the year 2002
  • D. Parkin
  • Medicine
  • International journal of cancer
  • 2006
TLDR
The fraction of the different types of cancer, and of all cancers worldwide and in different regions, has been estimated using several methods; primarily by reviewing the evidence for the strength of the association (relative risk) and the prevalence of infection in different world areas. Expand
...
1
2
3
4
5
...